References
- Chasseaud LF, Daragh A, Doyle E, RLambe RF, Tayllor T. Isosorbide dinitrate plasma concentration and bioavailability in human subjects after administration of standard oral and sublingual formulations. Journal of Pharmaceutical Sciences 1984; 73: 699–701
- Dinarvand R, Mirfattahi S, Atyabi F. Preparation, characterization and in vitro drug release of isosorbide dinitrate 2002. Journal of Microencapsulation 2002; 19: 73–81
- Gurny R, Doelker E, Peppas NA. Model of sustained release of water-soluble drug from porous, hydrophobic polymers. Biomaterials 1982; 3: 27–32
- Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
- Karkis JE, Corlin R, Mills RM, Williams RA, Schwitzer P, Ransil BJ. Sustained effects of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. American Journal of Cardiology 1979; 43: 265–271
- Khids SH, Niazy EM, El-Sayed YM. Preparation and in-vitro evaluation of metoclopramide hydrochloride microspheres. Journal of Microencapsulation 1995; 12: 651–660
- Khids SH, Niazy EM, El-Sayed YM. Development and in-vitro evaluation of sustained release meclofenamic acid microspheres. Journal of Microencapsulation 1998; 15: 153–162
- Laufen H, Aumann M, Leiold M. Oral adsorption and disposition of isosorbide dinitrate and isosorbide mononitrate in man. Drug Research 1983; 33: 980–984
- Moldenhauer MG, Narirn JG. Formulation parameters affecting the preparation and properties of microencapsulated ion-exchange resins containing theophylline. Journal of Pharmaceutical Sciences 1990; 79: 659–666
- Nozaki Y, Ohta M, Chien YW. Transmucosal controlled systemic delivery of isosorbide dinitrate: in vivo/in vitro correlation. Journal of Controlled Release 1977; 43: 105–114
- Nozaki Y, Yukimatsu Y, Mayumi T. A new transmucosal controlled systemic delivery of isosorbide dinitrate in vivo and in vitro evaluation in beagle dogs. S. T. P. Pharma Science 1996; 6: 134–141
- Platzer R, Reutemann G, Galeazzi RL. Pharmacokinetics of intraveneous isosorbide dinitrate. Journal of Pharmacokinetics and Biopharmaceutics 1982; 10: 575–586
- Strachl P, Pharm D, Galeazzi RL. Isosorbide dinitrate bioavailability, kinetics, and metabolism. Clinical Pharmacology Therapeutics 1985; 38: 140–149
- Thanoo BC, Sunny NC, Jayakrishinan A. Oral sustained release drug delivery systems using polycarbonate microspheres capable of flating on the gastric fluid. Journal of Pharmacy and Phomacology 1993; 45: 21–24
- Vyas SP, Jain C. Bioadlhesive polymer grafted starch microspheres bearing isosorbide dinitrate for buccal administration. Journal of Microencapsulation 1992; 9: 457–476